Alpine Bank Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Alpine Bank Wealth Management's VRTX Position: Q2 2026 in Review
Alpine Bank Wealth Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 192 shares worth $95.4K. The stake represents 0.01% of the portfolio and ranks #217 among its holdings. This is a return to the name: Alpine Bank Wealth Management previously reported a position in VRTX as recently as Q3 2025.
Alpine Bank Wealth Management first reported a position in VRTX in Q3 2024 and has held it in 5 quarters since. The position peaked at $143K in Q2 2025. 1,019 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Alpine Bank Wealth Management held 192 shares of Vertex Pharmaceuticals worth $95.4K as of Q2 2026.
- Vertex Pharmaceuticals was a new Alpine Bank Wealth Management position in Q2 2026.
- Vertex Pharmaceuticals made up 0.01% of Alpine Bank Wealth Management's portfolio in Q2 2026, its #217 holding.
- Alpine Bank Wealth Management first reported a position in Vertex Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
- Alpine Bank Wealth Management's Vertex Pharmaceuticals position peaked at $143K in Q2 2025.
- 1,019 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Alpine Bank Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.